A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorUniversity of Toronto

About this trial

This randomized controlled trial (RCT) will aim to examine the effect of a 12-week behavioural intervention on changing the sedentary behaviours (SB) of prostate cancer survivors (PCS) compared to a control group (FitBit-only group). PCS in the intervention group will receive a FitBit and 6 behavioural support sessions with a movement specialist guided by behavioural theory (i.e., the Multi-Process Action Control \[M-PAC\]). The FitBit-only group will only receive a FitBit and access to public health resources on physical activity (PA). The primary purpose of this study is to determine the efficacy of the intervention on changing SB of PCS immediately following the 12-week intervention and 6-months later. It is hypothesized that that the intervention will decrease their SB compared to the FitBit-only control condition at both timepoints. This trial will also examine the effect of the intervention on changing PA, motivational outcomes from the M-PAC framework, sleep quality, social support, physical function, quality of life, fatigue, disability and mental health compared to the active control condition.

Eligibility criteria

Qualifiers

>= 18 years of age

Diagnosed with localized or asymptomatic metastatic primary prostate cancer

Not currently undergoing radiation or chemotherapy

Proficient in English

Disqualifiers

Not planning to live in Canada for the next 12 months

A medical condition that prohibits walking (e.g., severe knee or hip arthritis)

Presence of other primary or recurrent invasive cancer (i.e., other than non-melanoma skin cancer)

Have had a prior fall within the last 12-months

Trial design

Treatments tested in this trial

  • Intervention
  • FitBit Only

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Toronto

Lead sponsor

Canadian Institutes of Health Research (CIHR)

Collaborator